Tianfeng Xu

15PUBLICATIONS
23CO-AUTHORS
Neural engineeringMolecular targetsCheminformatics and quantitative structure-activity relationshipsSeparation technologiesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 04, 2026
Glycoengineered Host-Guest Nanoparticles Potentiate Alzheimer's Disease Therapy via Lesion-Specific Modulation of Tau Pathology.

|Mar 26, 2026
Discovery of a selective CDK7 PROTAC against acute leukemia with low platelet toxicity.

Yutong Tu, Xiaojia Cai, Zhaofan Tao

|Feb 18, 2026
Design, Synthesis, and Structure-Activity Relationship Studies of 7H‑Pyrrolo[2,3‑d]pyrimidine Derivatives as Potent Casein Kinase 1α (CK1α) Inhibitors.

Meiying Liu, Yutong Tu, Wangyang Xu

|Feb 12, 2026
Construction of PROTAC Library via Liquid-Phase Synthesis Enabled by a Hydrophobic Tag.

Yifeng Zhou, Wei He, Zehui Zhou

|Aug 14, 2024
Design, Synthesis, and Biological Evaluation of 2,4-Diaminopyrimidine Derivatives as Potent CDK7 Inhibitors.

Hualin Zhang, Yutong Tu, Zhaofan Tao

|Aug 12, 2024
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9.

Changwei Wang, Mi Wang, Yu Wang

Pageof 3

Frequent Collaborators

5 joint publications

Yupeng Li

5 joint publications

Mingyue Zheng

5 joint publications

Duxin Sun

5 joint publications

Shaomeng Wang